| Previous Close | 34.62 |
| Open | 34.72 |
| Bid | 34.78 x 1800 |
| Ask | 34.79 x 900 |
| Day's Range | 34.65 - 34.89 |
| 52 Week Range | 28.47 - 39.74 |
| Volume | |
| Avg. Volume | 3,244,888 |
| Market Cap | 70.977B |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | 10.73 |
| EPS (TTM) | 3.23 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.40 (4.04%) |
| Ex-Dividend Date | Aug 17, 2023 |
| 1y Target Est | 39.63 |

A look at the stocks making headlines on Wednesday.

PHILADELPHIA, August 17, 2023--GSK announces AREXVY, its respiratory syncytial virus (RSV) vaccine, is now available at all major US retail pharmacies

Fool.com contributor Parkev Tatevosian evaluates GSK (NYSE: GSK) and its longer-term prospects to determine if it's a fantastic stock to buy for dividend stock investors. *Stock prices used were the afternoon prices of Aug.